Freeline Therapeutics Holdings plc - ADR
NASDAQ:FRLN 3:52:12 PM EDT
Earnings Announcements
Freeline Reports First Quarter 2022 Results And Business Highlights
Published: 05/10/2022 21:05 GMT
Freeline Therapeutics Holdings plc - ADR (FRLN) - Freeline Reports First Quarter 2022 Financial Results and Business Highlights.
Qtrly Loss per Share $0.63.
Q1 Earnings per Share View $-0.61 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Loss per Share $0.63.
Q1 Earnings per Share View $-0.61 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.50
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48
More details on our Analysts Page.